# A Feasibility Study to Evaluate Safety and Initial Effectiveness of ExAblate Transcranial MR Guided Focused Ultrasound for Bilateral Anterior Capsulotomy in the Treatment of Medication-Refractory MDD

> **NCT02348411** · NA · COMPLETED · sponsor: **Yonsei University** · enrollment: 4 (actual)

## Conditions studied

- Major Depressive Diorder

## Interventions

- **DEVICE:** ExAblate

## Key facts

- **NCT ID:** NCT02348411
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-08-27
- **Primary completion:** 2018-07-23
- **Final completion:** 2018-07-23
- **Target enrollment:** 4 (ACTUAL)
- **Last updated:** 2019-02-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02348411

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02348411, "A Feasibility Study to Evaluate Safety and Initial Effectiveness of ExAblate Transcranial MR Guided Focused Ultrasound for Bilateral Anterior Capsulotomy in the Treatment of Medication-Refractory MDD". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02348411. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*